Understanding the Placental Biology of Tobacco Smoke, Nicotine, and Marijuana (THC) Exposures During Pregnancy

Clin Obstet Gynecol. 2022 Jun 1;65(2):347-359. doi: 10.1097/GRF.0000000000000691. Epub 2022 Feb 4.

Abstract

Widespread public health campaigns have reduces the prevalence of tobacco and nicotine exposures during pregnancy in the United States. However, tobacco and nicotine exposures during pregnancy persist as a common modifiable perinatal risk exposure. Furthermore, declines in tobacco use have been accompanied by parallel rises in both the prevalence and incidence of marijuana use in pregnancy. This is worrisome, as the macromolecules which comprise tobacco and marijuana smoke affect placental function. In this chapter we summarize the decades of evidence contributing to our understanding of the placental molecular pathophysiology accompanying these chemical exposures, thereby rendering risk of adverse perinatal outcomes.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biology
  • Cannabis* / adverse effects
  • Dronabinol / adverse effects
  • Female
  • Humans
  • Nicotiana
  • Nicotine / adverse effects
  • Placenta
  • Pregnancy
  • Smoke / adverse effects
  • Tobacco Smoke Pollution* / adverse effects

Substances

  • Smoke
  • Tobacco Smoke Pollution
  • Nicotine
  • Dronabinol